Related by context. All words. (Click for frequent words.) 75 QT interval 73 Tasigna prolongs 72 QTc interval 72 corrected QT interval 72 prolonged QT interval 71 QRS duration 69 QTc intervals 68 QT prolongation 68 torsade de pointes 68 prolonged QT intervals 68 torsades de pointes 68 QTc prolongation 68 telomere lengths 67 repolarization 67 activated partial thromboplastin 67 induce orthostatic hypotension 67 aminotransferases 66 QRS interval 66 β blockers 66 QTc 65 parkinsonian 65 sinus tachycardia 65 arrhythmogenic 65 hyperalgesia 65 variant angina 65 lactate dehydrogenase LDH 65 QT interval prolongation 65 ventricular repolarization 65 ventricular arrhythmia 65 thyrotoxicosis 64 Brugada syndrome 64 tachyarrhythmias 64 lichen planus 64 INVEGA ® 64 ABCB1 64 cytopenias 64 colorectal adenoma 64 left ventricular dysfunction 64 ictal 64 SGPT 64 CK MB 64 cardiac repolarization 64 pathologic fracture 64 metabolic parameters 64 intravenous cyclophosphamide 64 intima media thickness 64 plasma lipids 63 postoperative AF 63 ribavirin therapy 63 electrophysiologic 63 endometrial thickness 63 troponin T 63 asystole 63 bullous pemphigoid 63 hypoperfusion 63 pharmacodynamic parameters 63 hypokalemia hypomagnesemia 63 CYP#A# substrates 63 Hypotension 63 autoregulation 63 paroxysmal AF 63 K ras mutations 63 bone marrow suppression 63 artery stenosis 63 serum aminotransferase levels 63 Paliperidone 63 QT QTc interval 63 hypothalamic pituitary 63 airflow obstruction 63 eosinophil count 63 nadolol 63 pulmonary arterial 63 thromboembolic complications 63 systolic ejection 63 glycosylated hemoglobin HbA1c 63 ACTOplus met XR 63 hematological parameters 63 extrapyramidal symptoms 63 monoamine oxidase inhibitors 63 Avandia Actos 63 flecainide 62 isoenzyme 62 adrenocorticotropic hormone 62 hypercalcemia 62 carcinoids 62 mdx mice 62 posttransplant 62 phenothiazines 62 neurologic progression 62 neurologic complications 62 glycated hemoglobin levels 62 ventricular fibrillation VF 62 akinesia 62 plasma creatinine 62 QT QTc 62 anemia thrombocytopenia 62 Ventricular fibrillation 62 rhythm disturbances 62 carotid IMT 62 cardioembolic stroke 62 lactate dehydrogenase 62 thrombocytopenic 62 airway hyper responsiveness 62 nortriptyline Pamelor 62 aspartate aminotransferase 62 serum phosphate 62 autoantibody levels 62 serum calcium levels 62 recurrent VTE 62 haematologic 62 tibolone 62 intact parathyroid hormone 62 hypothalamic pituitary adrenal axis 62 hyperprolactinemia 62 HIV HCV coinfected 62 anterior temporal 62 cTnT 62 cardiac conduction 62 ADPKD 62 QTcF 62 experimentally induced 62 coronary occlusion 62 alanine aminotransferase 62 QRS width 62 left ventricular systolic 62 IELT 62 neurocognitive function 62 recurrent venous thromboembolism 62 primary aldosteronism 62 coagulation parameters 62 hyperreflexia 62 antiphospholipid antibodies 62 cervicitis 62 postoperative delirium 62 antiarrhythmic medications 62 hyperglycaemia 61 glycogen metabolism 61 NATRECOR ® 61 hypokalemia 61 levodopa therapy 61 intraventricular 61 alteplase 61 neurodevelopmental outcome 61 antiarrhythmic drugs 61 hypoxemia 61 myoclonus 61 pyridostigmine 61 oral antidiabetic medication 61 ventricular tachyarrhythmias 61 cerebral ischemia 61 isoproterenol 61 parasitemia 61 thyrotropin 61 vasomotor 61 deep venous thromboses 61 clomipramine 61 alanine aminotransferase ALT 61 amisulpride 61 PR interval prolongation 61 stress cardiomyopathy 61 antiarrhythmic drug 61 lipoprotein levels 61 virological response 61 platelet activation 61 dyskinesias 61 PTPN# 61 antiandrogens 61 potentiation 61 infarcts 61 weekly subcutaneous injections 61 abnormal heartbeats 61 MULTAQ 61 electrical cardioversion 61 morphometric vertebral fractures 61 anticoagulant warfarin 61 aminotransferase levels 61 hypopneas 61 timepoints 61 hemodynamic parameters 61 bipolar mania trials 61 euthymic patients 61 ventricular tachyarrhythmia 61 elevated triglyceride levels 61 intravascular hemolysis 61 serum potassium 61 hypercholesterolaemia 61 immunomodulatory therapy 61 ICD shocks 61 intima media thickness IMT 61 gastrointestinal perforation 61 urate lowering therapy 61 sinus node 61 sotalol 61 plasma folate 61 serum cortisol 61 aspartate aminotransferase AST 61 silent ischemia 61 adrenal suppression 61 Leydig cell 61 pentoxifylline 61 tonic clonic seizures 61 autonomic dysfunction 61 dysfunction LVSD 61 primidone 61 syncope fainting 61 thyroglobulin 61 dopaminergic therapy 61 systolic dysfunction 61 VIIBRYD 61 Ribavirin causes 61 pulmonary artery pressure 61 neurologic dysfunction 61 hamartomas 61 carotid intima media 61 Torsades de Pointes 61 neurologic symptoms 61 tachycardias 61 bezafibrate 61 leukocyte counts 61 serum calcium 61 opioid analgesia 61 left ventricular hypertrophy 61 p# activation 61 heart arrhythmias 61 aromatase inhibitor therapy 61 baroreflex 61 IL 1ß 61 serum potassium levels 61 severe neutropenia 61 fluvastatin 61 jugular venous 61 cTnI 61 immunosuppressant therapy 61 TEAEs 61 endometrial hyperplasia 61 RLAI 61 allograft rejection 61 impair fertility 61 aneurysmal subarachnoid hemorrhage 61 acetabular dysplasia 61 hypocalcemia 61 loop diuretics 61 extrapyramidal symptoms EPS 61 T2DM 60 bronchial hyperresponsiveness 60 thyrotropin levels 60 GH deficiency 60 anterior uveitis 60 tardive dyskinesia TD 60 malperfusion 60 normotensive 60 artery occlusion 60 nicardipine 60 TNFalpha 60 bullous 60 #mg/day [002] 60 dobutamine 60 macrovascular disease 60 macroalbuminuria 60 creatinine clearance 60 coadministration 60 lymphocytosis 60 efalizumab 60 tumor histology 60 diastolic function 60 nmol liter 60 Tardive dyskinesia 60 serum BDNF 60 reinfarction 60 imipramine Tofranil 60 hepatic enzymes 60 ischaemia 60 ANCA associated 60 elevated IOP 60 hemorrhagic complications 60 leiomyomas 60 Prostatitis 60 cerebrovascular events 60 perioperatively 60 selective modulator 60 gonadotrophin releasing hormone 60 transfusion syndrome 60 myocardial ischemia 60 cerebral oxygenation 60 electroencephalographic 60 hyperphenylalaninemia HPA due 60 genotypic resistance 60 hypoglycemic episodes 60 overt hypothyroidism 60 hepatic enzyme 60 ULTRAM ER 60 transaminase levels 60 EEG abnormalities 60 oxcarbazepine 60 vecuronium 60 T wave alternans 60 thyroid hormone levels 60 hyperammonemia 60 MMP inhibitor 60 hyperacute 60 parkinsonian symptoms 60 serum lipid 60 ventricular remodeling 60 corticosteroid therapy 60 hepatorenal syndrome 60 hypogonadotropic hypogonadism 60 paricalcitol 60 unexplained syncope 60 prothrombin 60 dysrhythmias 60 hepatotoxicity 60 triiodothyronine 60 QT syndrome 60 asymptomatic carotid stenosis 60 IFN beta 60 SHBG levels 60 ancrod 60 rheumatoid factor 60 lipoprotein profiles 60 thrombocytopenic patients 60 salivary cortisol 60 F FDG PET 60 L dopa 60 PECAM 1 60 CC genotype 60 GnRH agonist 60 glucose homeostasis 60 MMSE score 60 complement inhibitor eculizumab 60 granulomatous 60 hyperkalemia 60 neurohormonal 60 endometrial carcinoma 60 NMIBC 60 INVEGA ™ 60 airway hyperresponsiveness 60 PRADAXA #mg 60 tryptase 60 leukoencephalopathy 60 pharmacodynamics PD 60 thrombotic complications 60 intracranial hemorrhage ICH 60 foveal thickness 60 d dimer 60 Known hypersensitivity 60 selective cerebral perfusion 60 dysmenorrhoea 60 monoclonal gammopathy 60 adrenal cortex 60 transdermal estradiol 60 SGOT 60 glomerular filtration 60 hypomagnesemia 60 growth hormone secretion 60 mutated K ras 60 cerebral vasospasm 60 leiomyoma 60 NPH insulin 60 delayed gastric emptying 60 elevated serum creatinine 60 pericardial effusions 60 chorioamnionitis 60 chloride secretion 60 metabolite concentrations 60 overt nephropathy 60 partial thromboplastin 60 K + ATPase 60 pCR 60 adriamycin 60 non valvular atrial 60 OGTT 60 serum urate levels 60 periprocedural 60 paroxetine sertraline 60 Ventricular Tachycardia 60 intracytoplasmic 60 Venous thromboembolism 60 endothelial activation 60 glycaemia 60 receptor inhibitor 60 hepatocellular 60 hepatic failure 60 dyskeratosis congenita 60 obstructive apnea 60 poor metabolizers 60 adrenocortical 60 hydrops 60 potassium sparing diuretics 59 PAOD 59 claudication 59 stratifying patients 59 atorvastatin #mg 59 serum phosphorous 59 pulmonary artery banding 59 baroreceptor 59 rCBF 59 AGHD 59 nonvertebral fracture 59 angiographically 59 alfuzosin 59 Mitral regurgitation 59 underwent coronary angiography 59 flutamide 59 Atypical antipsychotics 59 heterozygotes 59 nonischemic 59 bronchoalveolar lavage BAL 59 EXJADE 59 reflux disease GERD 59 intermittent hypoxia 59 dopamine antagonists 59 Postoperative complications 59 insulin detemir 59 SCN5A 59 coagulation abnormalities 59 colonic mucosa 59 myocardial fibrosis 59 serum IGF 59 Low density lipoprotein 59 euthyroid 59 nasal obstruction 59 receiving XGEVA 59 GI motility 59 fluoxetine Prozac 59 radiographic progression 59 locomotor activity 59 pulmonary toxicity 59 VKORC1 59 ventricular arrhythmias 59 μg liter 59 hypoglycemic events 59 echocardiographic parameters 59 nondiabetic patients 59 denervation 59 cortisol secretion 59 biochemical abnormalities 59 LQTS 59 β blocker 59 Hashimoto thyroiditis 59 mechanical dyssynchrony 59 airway narrowing 59 Paxil paroxetine 59 hemostatic efficacy 59 glucocorticoid therapy 59 dosing interval 59 atrial tachyarrhythmias 59 Hurthle cell 59 beta blocker therapy 59 sulfasalazine 59 NMDA antagonists 59 events TEAEs 59 ouabain 59 fasting triglycerides 59 antidepressants fluoxetine 59 Postoperatively 59 irbesartan 59 androgen deprivation 59 serum testosterone 59 coronary stenoses 59 serum urate 59 macrovascular events 59 #q# deletion 59 symptomatic VTE 59 pulmonary infiltrates 59 subclinical hypothyroidism 59 ritonavir boosted 59 myopathy rhabdomyolysis 59 Heavy menstrual bleeding 59 plasma pharmacokinetics 59 Glucocorticoids 59 platelet clumping 59 LV ejection fraction 59 lumbar spine BMD 59 Orthostatic hypotension 59 transthoracic 59 Severity MSCS score 59 luteal phase 59 achalasia 59 metabolic acidosis 59 hyperoxia 59 sonographic appearance 59 desipramine 59 progression TTP 59 HOMA IR 59 baroreceptors 59 tumor necrosis 59 ischemia induced 59 gadolinium enhanced 59 narrow QRS 59 impaired glucose metabolism 59 dopamine receptor gene 59 receiving VELCADE 59 postoperative complication 59 Mg Uk 59 allergic inflammation 59 ropinirole 59 ACh 59 vascular dysfunction 59 tolterodine 59 anaphylactic reactions bronchospasm 59 plasma triglycerides 59 polymorphic ventricular tachycardia 59 platelet inhibition 59 neuronal plasticity 59 progressive neurodegenerative disorder 59 postprandial glycemia 59 catecholamine 59 renal toxicity 59 Primary endpoints 59 electrocardiographic 59 serum PTH 59 neuronal dysfunction 59 plasma uric acid 59 hemodynamic variables 59 CP CPPS 59 inotropic 59 virologic failure 59 biphasic insulin aspart 59 VAPRISOL 59 endocrinologic 59 syncopal 59 cardiomyopathies 59 HER2 expression 59 riociguat 59 dosage regimens 59 hypophosphatemia 59 desvenlafaxine succinate 59 acute aortic dissection 59 chronic thromboembolic pulmonary 59 contrast echocardiography 59 lymphopenia 59 Index CDAI 59 genetic polymorphism 59 cerebral infarction 59 hemodilution 59 elevated ALT 59 decompensated heart failure 59 CrCl 59 PsA 59 pretransplant 59 neurohormones 59 oxygen desaturation 59 ventricular tachycardia VT 59 lacosamide 59 intracerebral 59 parkinsonism 59 aspirin clopidogrel 59 penile erection 59 crossclamp 59 pulmonary artery hypertension 59 serum magnesium 59 eosinophilia 59 fibrinolysis 59 nondiabetics 59 mild renal insufficiency 59 serum leptin 59 systemic hypotension 59 dysglycemia 59 PEGylated anti 59 intensive statin therapy 59 detrusor 59 underlying vasculopathy 59 LATUDA 59 APTIVUS r 59 MSLT 59 impaired cognition 59 inotropes 59 umbilical vein 59 creatine kinase 59 atrioventricular valve 59 levodopa induced 59 hematopoietic cancers 59 Dronedarone 59 abacavir lamivudine 59 ximelagatran 59 Erythropoietic therapies may 59 lung metastasis 59 intraocular pressure IOP 59 endocannabinoid signaling 59 ventricular tachycardia 59 Akt activation 59 recurrent atrial fibrillation 59 heparin induced thrombocytopenia 59 parasitaemia 59 DAPT 59 microtubule dynamics 59 metabolic dysfunction 59 status epilepticus 59 serum concentrations 59 glomerular 59 rebleeding 59 selegiline 59 antiandrogen 59 intracerebral haemorrhage 59 SSc 59 orthostatic 59 arteriolar 59 carotid atherosclerosis 59 thiazides 59 serum estradiol 59 ventricular dilation 59 salmeterol fluticasone 59 ventricular dilatation 59 nonfatal MI 59 erythrocyte sedimentation rate 59 anticoagulant medications 59 serum sodium levels 59 diabetes mellitus DM 59 circadian genes 59 cardiac troponin 59 severe renal impairment 59 SCr 59 pmol L 59 hemodialysis patients 59 hyperparathyroidism 59 renal insufficiency 59 chronicity 59 normal karyotype 59 PLMs 59 triacylglycerol concentrations 59 mTOR inhibitors 59 Acute pancreatitis 59 white matter hyperintensities 59 hypercalcaemia 59 asthma exacerbation 59 neuroleptic 59 hypercalciuria 59 vasogenic edema 59 dermatologic reactions 59 hypopnea 59 myocardial dysfunction 59 lethal arrhythmias 59 postintervention 59 propranolol Inderal 59 PTHrP 59 fractional shortening 59 hypoventilation 58 long QT syndrome 58 pg mL 58 onset atrial fibrillation 58 ertapenem 58 hypoglycaemic episodes 58 inhibitor RG# 58 anticlotting drugs 58 monoamine oxidase inhibitors MAOIs 58 adiponectin levels 58 depressive symptomatology 58 stable angina 58 thromboembolism 58 CAG repeats 58 posaconazole 58 transaminase elevations 58 hyperactivation 58 GABRA2 58 PSA nadir 58 thromboembolic 58 AST ALT 58 symptomatic intracranial 58 microalbuminuria 58 severe hypersensitivity reactions 58 5 HTTLPR 58 Severe hypoglycemia 58 haemolysis 58 Chronic pancreatitis 58 nocturnal hypoglycaemia 58 benazepril 58 atrioventricular block 58 unstable angina pectoris 58 hypotensive 58 tissue oxygenation 58 amenorrhoea 58 nausea constipation 58 serum retinol 58 fraction LVEF 58 estimated glomerular filtration 58 transgene expression 58 Obstructive sleep apnea OSA 58 paroxetine Paxil 58 anaphylactoid reactions 58 corticosteroid dose 58 thrombotic events 58 spirometric 58 cAMP signaling 58 hypovolemic 58 vasodilatation 58 Non inferiority 58 thrombocytosis 58 prostate cancer CaP 58 dyssynchrony 58 mRNA expression 58 antiretroviral naive 58 IDDM 58 erythropoietic 58 imatinib therapy 58 divalproex sodium 58 vasodilation 58 creatine kinase MB 58 diabetic gastroparesis 58 androgen suppression 58 proliferative diabetic retinopathy 58 cortical activation 58 cysteines 58 retinal ischemia 58 LV dysfunction 58 serum homocysteine 58 alpha blocker 58 baroreflex sensitivity 58 leucopenia 58 microcirculatory 58 hsCRP levels 58 preserved ejection fraction 58 cerebral perfusion 58 edifoligide 58 ^ sup #m 58 prolactin levels 58 physiological abnormalities 58 urticaria hives 58 leptin deficient mice 58 choroidal vasculopathy 58 apnea hypopnea index 58 pathologic fractures 58 valvular heart disease 58 AGILECT R 58 glomerular filtration rate 58 fulvestrant 58 hour bronchodilation 58 dose proportional pharmacokinetics 58 PLX STROKE targeting 58 neovascular 58 sustained ventricular tachycardia 58 platelet aggregation 58 electrical conduction 58 bronchopulmonary dysplasia 58 thiazide 58 platelet reactivity 58 MGUS 58 mutated KRAS 58 affective psychosis 58 atrioventricular 58 thromboembolic events 58 rearfoot 58 transferrin saturation 58 interleukin IL -# 58 intravitreal injections 58 pancytopenia 58 Crohn Disease Activity 58 tolvaptan 58 Endothelial dysfunction 58 HLA DRB1 * 58 pheochromocytoma 58 diabetic kidney 58 bladder contractions 58 hyperplastic 58 leptin deficiency 58 captopril 58 genetic polymorphisms 58 hepatic function 58 hypoxia induced 58 abdominal adiposity 58 lesional 58 pericardial effusion 58 arousals 58 albumin excretion rate 58 neutrophil counts 58 nonfatal myocardial infarction MI 58 undergoing coronary artery 58 contractile function 58 IgA deficiency 58 iPTH 58 LRP5 58 lactic acidosis 58 Cardiac arrhythmias 58 serum ALT 58 subchronic 58 Cotinine 58 Selective serotonin reuptake inhibitors 58 adipogenic 58 distensibility 58 ERK1 2 58 clopidogrel Plavix 58 atherogenic dyslipidemia 58 natriuretic peptides 58 FDG uptake 58 amylin 58 urolithiasis 58 antihypertensive therapy 58 neutropenia dehydration dyspnea 58 elevated creatinine 58 Cardiopulmonary bypass 58 physiologic parameters 58 steroidogenic 58 CCyR 58 diastolic hypertension 58 etiologic 58 gefitinib Iressa 58 prolactin elevation 58 ACTOplus met 58 renal tubular 58 #q# deletion syndrome 58 tricuspid regurgitation 58 beta adrenergic receptor 58 metaplasia 58 vWD 58 Thal Dex 58 liver histology 58 left ventricular diastolic 58 ischemic cardiomyopathy 58 Refractory Hodgkin Lymphoma 58 lung edema 58 neuroleptics 58 visilizumab 58 Mg Usa 58 OSAHS 58 chest radiographs 58 olmesartan 58 relapsed MM 58 syndrome OSAS 58 basilar artery 58 bolus dose 58 frequent awakenings 58 #mg doses [002] 58 microvascular disease 58 serum lipid levels 58 SLC#A# [002] 58 intra arterial injection 58 rs# [002] 58 streptokinase 58 HbA1c levels 58 idarubicin 58 hippocampal function 58 microvascular complications 58 gastroduodenal 58 perioperative complications 58 persistent pulmonary hypertension 58 daytime alertness 58 anthracycline chemotherapy 58 Cluster headaches 58 pituitary hormone 58 transaminases 58 procalcitonin 58 serum TSH 58 monoamines 58 thyroid stimulating hormone 58 induced sputum 58 methylation patterns 58 pressure natriuresis 58 placebo dummy pill 58 plasminogen activator inhibitor 58 cardiac troponin T 58 arterial calcification 58 methacholine 58 risperidone Risperdal 58 allopregnanolone 58 analgesic effects 58 Infusion Reactions Severe 58 Thyroid hormone 58 colorectal adenomas 58 leukocyte count 58 pharmacokinetic interactions 58 VT VF 58 leflunomide 58 HBeAg negative 58 troponins 58 hemodynamics 58 Left Ventricular Ejection Fraction 58 Hyperthyroidism 58 zoledronate 58 inhaled budesonide 58 coronary stenosis 58 systolic hypertension 58 micronuclei 58 ZOLINZA 58 Intussusception 58 NNT = 58 PSVT 58 antiphospholipid syndrome 58 metabolic abnormalities 58 predisposing factor 58 ziprasidone 58 bronchoconstriction 58 CK # administered 58 bronchodilatory 58 ICDs implanted 58 headache abdominal pain 58 arrythmia 58 inotropic agents 58 BH4 58 homozygotes 58 hamartoma 58 type2 diabetes 58 creatinine levels 58 immunological responses 58 Parkinsonian 58 apneic episodes 58 HMGA2 58 paclitaxel eluting stents 58 chromosomal aberrations 58 CMV infections 58 gastric carcinoma 58 mL/min/#.# m 2 58 serum creatinine levels 58 silent myocardial ischemia 58 cytopenia 58 bronchopulmonary dysplasia BPD 58 secondary hyperparathyroidism 58 corticotropin releasing hormone 58 #mg/day [001] 58 nerve conduction velocity 58 gastric adenocarcinoma 58 Diabetic nephropathy 58 NIASPAN 58 IFN γ 58 dose proportionality 58 cardiac biomarkers 58 sertraline Zoloft 58 penile fibrosis 58 NYHA functional class 58 analgesic medications 58 atrophic gastritis 58 intracardiac 58 elevated cortisol 58 neurologic deficits 58 atherothrombotic 58 blood glucose concentrations 58 Diabetic neuropathy 58 acute mania 58 alkalosis 58 5 HT1A 58 circadian cycle 58 gastro esophageal reflux 58 daytime drowsiness 58 paroxysmal supraventricular tachycardia 58 idraparinux 58 BYSTOLIC 58 virologic breakthrough 58 androgen ablation 58 urethral strictures 58 refractory ischemia 58 raphe 58 rate variability HRV 58 colocalization 58 lumbar spine bone 58 anticholinergic agents 58 preintervention 58 rt PA 58 antigen PSA levels 58 cardiac dysfunction 58 metastatic neuroendocrine tumors 58 intrahepatic 58 oral anticoagulation 58 renal dysfunction 57 angiotensin converting enzyme 57 coagulopathy 57 oral antidiabetic drugs 57 argatroban 57 TT genotype 57 6MWD 57 Stent thrombosis 57 glucose tolerance test 57 anti coagulant therapy 57 pharmacokinetics PK 57 adenotonsillectomy 57 postop 57 vitamin B# folic acid 57 exhaled nitric oxide 57 aminotransferase 57 beta agonists 57 multivariable Cox 57 PULMICORT RESPULES 57 cilostazol 57 metabolic syndrome MetS 57 pamidronate 57 histopathologic examination 57 PSADT 57 erythropoiesis 57 HeFH 57 ejaculatory dysfunction 57 TNF Tumor Necrosis Factor 57 acromegalic patients 57 hyperthermic 57 valvular disease 57 glycemia 57 EFFEXOR XR 57 antibody titer 57 CIMZIA ™ 57 myocardial infarction stroke 57 bypass grafting 57 unprovoked seizures 57 vasodilators 57 CTEPH 57 interferon therapy 57 thyroid dysfunction 57 LVSD 57 arrythmias 57 airflow limitation 57 noncardiac 57 induced ischemia 57 Helicobacter pylori eradication 57 hours postdose